The short answer
Bleeding after treatment for endometrial cancer is the signal that gets looked into. There is no blood test that tracks this cancer, so exams, scans and your own report carry the weight. Mismatch repair and POLE results shape the drug choices.
Any bleeding or new discharge after a hysterectomy deserves a call, however long ago treatment ended.
NCI's summary describes no blood marker used to follow endometrial cancer, so exam findings and symptoms drive detection.
Vaginal cuff brachytherapy treats a much smaller area than whole-pelvis external beam radiation, so which one fits depends on stage and where any earlier beams went.
Mismatch repair status sorted patients in both the pembrolizumab-lenvatinib and RUBY dostarlimab trials, so ask what yours showed.
Choose how you want to understand this
The full explanation.
Bleeding is the signal that matters most
After a hysterectomy there is no period to explain away bleeding. Any bleeding or new discharge deserves a call. That holds true years later.
NCI gives similar advice in a different setting: a woman taking tamoxifen who has abnormal vaginal bleeding should have a follow-up exam, and a biopsy of the lining if needed. That guidance is about tamoxifen, not about follow-up after treatment. Still, no one benefits from waiting bleeding out. Ask your own team what their plan is for checking it.
Where endometrial cancer tends to return
A recurrence is usually found on an exam, or on a scan ordered because of a symptom. The NCI summary describes no blood test used to follow this cancer after treatment.
That gap is worth naming out loud. If no marker is being drawn, the pelvic exam and your own report carry the weight.
Radiation to the top of the vagina
Brachytherapy at the vaginal cuff is radiation given where the cervix used to sit. It treats a far smaller area than beams aimed at the whole pelvis, which is why the two are not interchangeable. Which one suits you turns on stage, where the disease is, and what field you were treated in before.
If you never had radiation, that route may still be open. If you did, ask exactly where the beams went.
Retesting the tumor before drugs are chosen
A large gene study split this cancer into four groups. One of them is the POLE group. NCI says that group has real meaning: the prognosis is good, and adjuvant therapy after surgery is often avoided. Whether that applies to you depends on the rest of the pathology, so ask rather than assume.
Two trials shape the drug list NCI now gives. In one, pembrolizumab and lenvatinib were compared with chemotherapy after platinum drugs stopped working. In the other, called RUBY, dostarlimab was added to chemotherapy. The gain was largest in women whose tumor had a fault in mismatch repair.
Both trials sorted women by that same test. So ask whether yours has been done, and what it showed.
Questions for the gynecologic oncologist
- Which finding started this: bleeding, an exam, or a scan?
- Will you biopsy it before changing anything?
- Is it only at the top of the vagina, or beyond the pelvis?
- Have I had radiation there before? Can I have it now?
- What did my mismatch repair and POLE tests show?
- Does that make dostarlimab or pembrolizumab an option?
- Is surgery still on the table, or is this a drug decision?
Ask which result is still pending. Ask whether waiting for it changes anything, and ask for the plan in the visit notes.
When to get help sooner
- Call 911 or go to an emergency department if vaginal bleeding soaks through a pad and does not slow, or you feel faint or pass out with it. Do the same for sudden shortness of breath, sharp chest pain, or coughing up blood. Those can mean a clot in the lung.
- Call your care team the same day if vaginal bleeding or spotting starts again after menopause, or if bleeding between periods is new for you. Also call for new pelvic pain, or for one leg that becomes swollen, red, or painful.
- Call your care team within a day or two if vaginal discharge changes, urinating becomes difficult or painful, sex becomes painful, or your bowel or bladder habits change.
Related pages
Cancer Staging and Biomarker Testing explain the terms that come up most when endometrial cancer comes back. Clinical Trial vs Standard Treatment, Palliative Care, and Questions to Ask Your Doctor cover the decisions that follow an endometrial cancer recurrence.
Where this comes from
These questions were drawn from current patient guidance for endometrial cancer:
Words to know
Tap any term to see what it means.
Common questions
Is bleeding after treatment always a recurrence?
No, but it is always worth checking. NCI's guidance for women on tamoxifen is that abnormal vaginal bleeding should prompt a follow-up exam, and a biopsy of the endometrial lining if needed. That advice is written for women taking tamoxifen rather than for recurrence follow-up, but the habit is the same: bleeding gets looked at.
Will a blood test tell us it has come back?
The NCI summary does not describe a blood marker used to follow endometrial cancer after treatment. That is why the pelvic exam and what you report matter so much.
Can I have radiation if I had it before?
It depends on where the earlier beams went. Brachytherapy at the vaginal cuff treats a much smaller area than radiation to the whole pelvis, so ask your team exactly what you received and over which field.
Which test decides whether immunotherapy is an option?
Mismatch repair status. In the RUBY trial, adding dostarlimab to chemotherapy helped most in women whose tumor had a mismatch repair fault. POLE results matter too. NCI describes the POLE ultramutated group as carrying a good prognosis, one where adjuvant therapy is often held back, though that judgement is made case by case with the full pathology.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
Turn this topic into questions for your next appointment.
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-08-11 what this meansLast updated: 2026-08-19Next planned review: 2028-07-30
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
High-risk topic — talk to your care team. This topic can involve urgent, individual medical decisions. This page is general education only: it cannot tell you whether your situation is an emergency or what you personally should do. Follow your oncology team's instructions and contact them for individual guidance.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
- Endometrial Cancer: A Plain-Language Overview
- Cancer Staging: What the Stage Means
- Biomarker Testing and Precision Medicine
- Getting a Second Opinion After a Diagnosis
- Questions to Ask About Endometrial Cancer Treatment
- Metastatic Endometrial Cancer: What to Ask
- Endometrial Cancer Survivorship Follow-Up Questions
- Coping With Fear of Recurrence
Still have questions?
Educational answers, plain language
Free to print and share